Skip to main content
. 2022 Jan 10;22:44. doi: 10.1186/s12879-022-07028-8

Table 2.

Factors associated with seropositivity for HPV-16, HPV seroprevalence study (n = 12,257, sera collected 2003–2006) (results from regression analysis)

Crude PR (95% CI) p-value Fully adjusted PR (95% CI)a p-value
Gender nsb
 Female Ref
 Male 1.1 (0.8–1.4) 0.706
Age group (years)
 1–3 Ref Ref
 4–6 1.5 (0.8–3.0) 0.196 1.5 (0.8–3.0) 0.198
 7–9 1.6 (0.8–3.3) 0.158 1.6 (0.8–3.2) 0.167
 10–11 1.6 (0.8–3.2) 0.184 1.6 (0.8–3.1) 0.195
 12–13 1.4 (0.7–2.8) 0.331 1.4 (0.7–2.8) 0.348
 14–15 2.0 (1.1–3.7) 0.018 2.1 (1.2–3.7) 0.015
 16–17 3.0 (1.6–5.5) 0.001 3.0 (1.6–5.6) 0.001
Region of residence
 West Germany Ref Ref
 East Germany 0.7 (0.5–1.0) 0.055 0.7 (0.5–1.0) 0.025
Urbanity nsb
 Rural Ref
 Small city 0.8 (0.6–1.3) 0.423
 Medium sized city 0.9 (0.6–1.3) 0.499
 Large city 0.8 (0.5–1.3) 0.370
Socioeconomic status of parents nsb
 Low Ref
 Middle 0.8 (0.6–1.1) 0.132
 High 0.8 (0.5–1.1) 0.134
Migratory background of parents nsb
 None Ref
 One parent 0.9 (0.5–1.5) 0.596
 Both parents 1.3 (1.0–1.9) 0.077
Number of household members 1.0 (0.9–1.1) 0.752 nsb
Number of siblings in household 0.9 (0.8–1.1) 0.225
Body Mass Index (BMI) 1.0 (1.0–1.1) < 0.001 nsb

PR prevalence ratio, CI confidence interval, Ref reference

aMutually adjusted for all other variables in the model

bns = variables were not significantly associated with HPV seroprevalence in the final model and therefore excluded